Clinical Trials Logo

Clinical Trial Summary

Enrolled neonates will be provided routine supportive care as per existing neonatal intensive care unit (NICU)protocols. This will be carried out in the initial 6 months (0-180 days) of study commencement. This group will serve as control group (group A). During subsequent 6 months (181-360 days) of the study period, enrolled neonates fulfilling the inclusion criteria will be provided routine supportive care and the components of developmentally supportive care (DSC).


Clinical Trial Description

Enrolled neonates will be provided routine supportive care as per existing NICU protocols. This will be carried out in the initial 6 months (0-180 days) of study commencement. This group will serve as control group (group A). During subsequent 6 months (181-360 days) of the study period, enrolled neonates fulfilling the inclusion criteria will be provided routine supportive care and the components of developmentally supportive care (DSC). DSC components will be strictly emphasized on protected sleep, pain and stress assessment and management, activities of daily living (positioning, feeding and skin care), the healing environment. This group will be designated as group B. Both the groups will receive appropriate management for their morbidities as per existing NICU protocols. Both the groups will be followed up till 37 weeks of gestation where in their neurobehavioral assessment will be performed using Neurobehavioural assessment of preterm infants score.

In both the groups all the baseline data regarding antenatal factors will be recorded in a predesigned proforma such as age, gravid, Gestational age, Chorioamnionitis, Prenatal steroids, Multiple pregnancy, maternal comorbidities (preeclampsia, gestational diabetes mellitus), mode of delivery etc. ;


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT02817022
Study type Interventional
Source Lady Hardinge Medical College
Contact VIKRAM DATTA, MD,DNB
Phone 91-1123344151
Email drvikramdatta@gmail.com
Status Recruiting
Phase N/A
Start date January 2016
Completion date June 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03896893 - Neonatal Bacterial Colonization Study N/A
Completed NCT01350765 - Naushero Feroze Neonatal Survival Project N/A
Completed NCT03403530 - Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates Phase 4
Completed NCT01360528 - Serum Folic Acid Levels in Preterm Infants N/A
Completed NCT06379178 - Effect of Oral Colostrum Applications Every 2 Hours and 4 Hours In Order to Achieve Trophic Feeding in Preterm Infants N/A
Completed NCT01335490 - Intervening to Improve Infant Health in Ghana N/A
Completed NCT03214822 - Human-derived Human Milk Fortifiers (H2MF), Gut Microbiota and Oxidative Stress in Premature Infants N/A
Completed NCT01220687 - Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation N/A